Malignant ovarian neoplasms: The place of conservative surgery

Annals of the New York Academy of Sciences

Volumn 816, Issue , 1997, Pages 362-368

  Tserkezoglou, Aliki J ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; CYSTECTOMY; EPITHELIUM CELL; FEMALE; FEMALE FERTILITY; GERM CELL TUMOR; HUMAN; OVARY CANCER; PREGNANCY; SALPINGOOOPHORECTOMY; SEX CORD TUMOR;

EID: 0030738012     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52162.x     Document Type: Conference Paper

References (16)

1. MUNNEL, E. Q. 1969. Is conservative therapy ever justified in stage I (Ia) cancer of the ovary? Am. J. Obstet. Gynecol. 1: 641-653.
2. DISAIA, P. & W. CREASMAN. 1993. The adnexal mass and early ovarian cancer. Epithelial ovarian cancer. In Clinical Gynecologic Oncology. S. Manning, Ed. Chapt. 10 and 11: 324-358. Mosby Year Book Inc. St. Louis, MO.
3. MORROW, P. 1992. Malignant and borderline epithelial tumors of the ovary: Clinical features, staging, diagnosis, intraoperative assessment and review of management. In Gynecologic Oncology. M. Coppleson, Ed. Vol. 2: 889-915. Churchill. Livingston. Hong Kong.
4. LIM-TAN, K. S., H. E. CAJIGAS & R. E. SCULLY. 1988. Ovarian cystectomy for serous borderline tumors. A follow-up study of 35 cases. Obstet. Gynecol. 72: 775-780.
5. BOSTWICK, D. G., H. D. TAZELAAR, S. C. BALLON, M. R. HENDRICKSON & R. L. KEMPSON. 1986. Ovarian epithelial tumors of borderline malignancy. Cancer 58: 2052-2065.
6. TAZELAAR, H. D., D. G. BOSTWICK, S. C. BALLON, M. R. HENDRICKSON & R. L. KEMPSON. 1985. Conservative treatment of borderline ovarian tumors. Obstet. Gynecol. 66: 417-422.
7. TRIMBOS, C. L. & E. L. TRIMBLE. 1994. Management of epithelial ovarian tumors of low malignant potential. Gynecol. Oncol. 55: S52-61.
8. KAERN, J., C. TROPE & V M. ABELER. 1993. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. Cancer 71: 1810-1820.
9. GERSHENSON, D. M. & E. G. SILVA. 1990. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 65: 578-585.
10. SUTTON, G. P., B. N. BUNDY, G. A. OMURA, E. L. YORDAN, J. B. BEECHAM & T. BONFIGLIO. 1991. Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy. (A Gynecologic Oncology group study). Gynecol. Oncol. 41: 230-233.
11. BENJAMIN, J. & S. C. RUBIN. 1994. Management of early stage epithelial ovarian cancer. Obstet. Gynecol. Clin. N. Am. 21: 107-120.
12. TRIMBLE, E. L. 1994. National Institutes of Health Consensus Development Conference Statement. Ovarian Cancer: Screening, Treatment and Follow Up. Gynecol. Oncol. 55: S1-14.
13. COLOMBO, N., S. A. CHIARI, N. MAGGIONI, et al. 1994. Controversial issues in the management of early epithelial ovarian cancer: Conservative surgery and role of adjuvant therapy. Gynecol. Oncol. 55: 547-551.
14. GERSHENSON, D. M. 1992. Malignant germ cell tumors of the ovary: Clinical features and management. In Gynecologic Oncology. M. Coppleson, Ed. Vol. 2: 935-945. Churchill. Livingston. Hong Kong.
15. GERSHENSON, D. M. 1994. Management of early ovarian cancer: Germ cell and sex cord-stromal tumors. Gynecol. Oncol. 55: S62-72.
16. HOSKINS, W. L. & S. C. RUBIN. 1992. Malignant gonadal stromal tumors of the ovary: Clinical features and management. In Gynecologic Oncology. M. Coppleson, Ed. Vol. 2: 961-970. Churchill. Livingston. Hong Kong.